Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore.
Undervalued average dividend payer.
Share Price & News
How has Virtus Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VRT's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: VRT underperformed the Australian Healthcare industry which returned -17.7% over the past year.
Return vs Market: VRT underperformed the Australian Market which returned -22.9% over the past year.
Price Volatility Vs. Market
How volatile is Virtus Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StWhat Is Virtus Health's (ASX:VRT) P/E Ratio After Its Share Price Tanked?
3 weeks ago | Simply Wall StVirtus Health Limited (ASX:VRT) Insiders Increased Their Holdings
1 month ago | Simply Wall StDo You Know About Virtus Health Limited’s (ASX:VRT) ROCE?
Is Virtus Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: VRT (A$1.56) is trading below our estimate of fair value (A$6.36)
Significantly Below Fair Value: VRT is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: VRT is good value based on its PE Ratio (4.4x) compared to the Healthcare industry average (11.6x).
PE vs Market: VRT is good value based on its PE Ratio (4.4x) compared to the Australian market (12.6x).
Price to Earnings Growth Ratio
PEG Ratio: VRT is poor value based on its PEG Ratio (18.7x)
Price to Book Ratio
PB vs Industry: VRT is good value based on its PB Ratio (0.4x) compared to the AU Healthcare industry average (1x).
How is Virtus Health forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VRT's forecast earnings growth (0.2% per year) is below the savings rate (1.1%).
Earnings vs Market: VRT's earnings (0.2% per year) are forecast to grow slower than the Australian market (9.7% per year).
High Growth Earnings: VRT's earnings are forecast to grow, but not significantly.
Revenue vs Market: VRT's revenue (2.3% per year) is forecast to grow slower than the Australian market (4% per year).
High Growth Revenue: VRT's revenue (2.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VRT's Return on Equity is forecast to be low in 3 years time (8.4%).
How has Virtus Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VRT has high quality earnings.
Growing Profit Margin: VRT's current net profit margins (10.2%) are lower than last year (10.6%).
Past Earnings Growth Analysis
Earnings Trend: VRT's earnings have declined by -1.4% per year over the past 5 years.
Accelerating Growth: VRT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: VRT had negative earnings growth (-0.2%) over the past year, making it difficult to compare to the Healthcare industry average (8.7%).
Return on Equity
High ROE: VRT's Return on Equity (10.2%) is considered low.
How is Virtus Health's financial position?
Financial Position Analysis
Short Term Liabilities: VRT's short term assets (A$27.6M) do not cover its short term liabilities (A$58.3M).
Long Term Liabilities: VRT's short term assets (A$27.6M) do not cover its long term liabilities (A$269.5M).
Debt to Equity History and Analysis
Debt Level: VRT's debt to equity ratio (60.7%) is considered high.
Reducing Debt: VRT's debt to equity ratio has increased from 60.2% to 60.7% over the past 5 years.
Debt Coverage: VRT's debt is well covered by operating cash flow (26.6%).
Interest Coverage: VRT's interest payments on its debt are well covered by EBIT (4.5x coverage).
Inventory Level: VRT has a low level of unsold assets or inventory.
Debt Coverage by Assets: VRT's debt is not covered by short term assets (assets are 0.2x debt).
What is Virtus Health's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: VRT's dividend (15.38%) is higher than the bottom 25% of dividend payers in the Australian market (3.35%).
High Dividend: VRT's dividend (15.38%) is in the top 25% of dividend payers in the Australian market (8.5%)
Stability and Growth of Payments
Stable Dividend: VRT has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: VRT has only been paying a dividend for 6 years, and since then payments have not increased.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (67%), VRT's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: VRT's dividends in 3 years are forecast to be covered by earnings (63.1% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Glenn Powers (59yo)
Mr. Glenn Powers has been the Group Chief Financial Officer and Company Secretary of Virtus Health Limited since joining it in August 2008. Mr. Powers has been an Interim Chief Executive Officer of Virtus ...
CEO Compensation Analysis
Compensation vs Market: Glenn's total compensation ($USD267.35K) is about average for companies of similar size in the Australian market ($USD245.34K).
Compensation vs Earnings: Glenn's compensation has been consistent with company performance over the past year.
|Group CFO & Company Secretary||no data||AU$435.88k||0.14% A$179.2k|
|Chief Information Officer||1.42yrs||AU$474.62k||no data|
|Medical Director of Victoria & Executive Director||6.83yrs||AU$170.27k||1.03% A$1.3m|
|Managing Director of Queensland & Virtus Health Diagnostics||no data||AU$319.11k||no data|
|Managing Director of Victoria & Tasmania||3.25yrs||AU$296.37k||no data|
|Managing Director of Europe||2.58yrs||AU$318.61k||no data|
|Managing Director of Singapore||4.42yrs||no data||no data|
|Medical Director of Singapore||1.17yrs||no data||no data|
|Managing Director of NSW||1.17yrs||no data||no data|
Experienced Management: VRT's management team is considered experienced (2 years average tenure).
|Medical Director of Victoria & Executive Director||6.83yrs||AU$170.27k||1.03% A$1.3m|
|Director||no data||no data||no data|
|Independent Non-Executive Director||0.50yr||no data||0.025% A$31.4k|
|Independent Chairman of the Board||0.33yr||AU$99.65k||0.056% A$70.7k|
|Non-Executive Director||1.5yrs||AU$71.75k||no data|
|Executive Chairman of Ireland||no data||AU$48.59k||no data|
|Independent Non-Executive Director||3.42yrs||AU$100.17k||0.0063% A$7.9k|
Experienced Board: VRT's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: VRT insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Virtus Health Limited's company bio, employee growth, exchange listings and data sources
- Name: Virtus Health Limited
- Ticker: VRT
- Exchange: ASX
- Founded: 2008
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: AU$125.466m
- Shares outstanding: 79.91m
- Website: https://www.virtushealth.com.au
Number of Employees
- Virtus Health Limited
- 176 Pacific Highway
- Level 3
- New South Wales
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|VRT||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jun 2013|
|V6H||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jun 2013|
|VRT||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jun 2013|
Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It operates through two segments, Healthcare Services Australia and Healthcare Services International. The company provides fertility care and related specialized diagnostics, as well as day hospital services. It offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, intracytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services. The company also provides endocrinology, andrology, preimplantation genetic, and cytogenetic diagnostic services; and gynecological and obstetric ultrasound scanning and procedures. In addition, it offers day hospital procedures, such as IVF, endoscopy, gynecology, urology, dental, ophthalmic, and cosmetic and plastic surgery. As of August 20, 2019, the company operated through a network of 127 fertility specialists. Virtus Health Limited was founded in 2008 and is headquartered in Greenwich, Australia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/30 10:41|
|End of Day Share Price||2020/03/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.